TP53 and breast cancer: However, the failure to confirm the association of TP53 rs1042522 within the replication cohort and the loss of its statistical significance in the overall population after correction for multiple testing or adjustment for clinical confounders indicate that we should consider this result as preliminary evidence requiring confirmation in larger cohorts of breast cancer patients.